E-coaching by Tailored Cognitive-behavioral Therapy in Chronic Somatic Conditions
|
If you are the presenter of this abstract (or if you cite this abstract in a talk or on a poster), please show the QR code in your slide or poster (QR code contains this URL). |
Abstract
Tailored Cognitive-behavioral Therapy in Chronic Somatic Conditions
dr. A.W.M. Evers 1,2,3, drs. M. Ferwerda 1, drs. S. van Beugen 1, dr. E. de Jong 3, dr. W. Kievit 2 , prof. M. van de Laar 4,5 , dr. E. Taal 4, prof. dr. P.C.M. van de Kerkhof 3, prof. dr. P.L.C.M. van Riel 2
1 Department of Medical Psychology, Radboud University Nijmegen Medical Centre, The Netherlands
2 Department of Rheumatology, Radboud University Nijmegen Medical Centre, The Netherlands
3 Department of Dermatology, Radboud University Nijmegen Medical Centre, The Netherlands
4 Department of Psychology, University of Twente, The Netherlands
5 Department of Rheumatology, Medisch Spectrum Twente, The Netherlands
Topic: E-coaching (Special topic, Medicine 2.0 “10)
Objectives: Psychological adjustment problems of high-risk patients with chronic somatic conditions, such as rheumatoid arthritis (RA), psoriasis (PS) and arthritis psoriatica (PSA), can be successfully treated by tailored cognitive-behavior therapy (CBT). Offering this tailored CBT by E-coaching for patients at risk might be a promising way to offer these treatments more cost-effectively. The aim of the study is to investigate the feasibility and effectiveness of tailored CBT through E-coaching for risk groups of patients with RA, PS and PSA.
Target groups: Patients with chronic somatic conditions.
Methodology: Patients’ satisfaction and the feasibility of tailored CBT by E-coaching for patients at risk were studied in a pilot study. Patients’ perspective with regard to possible advantages and disadvantages to participate in the treatment were additionally determined. In the randomized, controlled trial , patients with RA, PS and PSA were screened for cognitive-behavioral risk profiles, and subsequently were randomized to tailored E-coaching CBT or a control group.
Results: Results of the pilot study indicate that applying tailored E-coaching CBT to risk groups of RA, PSA and PSA patients is feasible and more advantages than disadvantages are perceived by patients for E-health treatments. Preliminary results on the effectiveness of the treatments in the treatment group suggest beneficial effects for physical and psychological functioning and low dropout rates during therapy.
Conclusion: E-coaching by tailored CBT for patients with chronic somatic conditions, such as RA, PS or PSA, seems to be feasible and a promising new cost-effective way to offer cognitive-behavioral treatment to patients who are at risk for psychological adjustment problems. Preliminary results of the randomized, controlled trials suggest high adherence and high patient satisfaction.
Correspondance:
Andrea W.M. Evers, PhD
Department of Medical Psychology 840
Radboud University Nijmegen Medical Centre
P.O. Box 9101
6500 HB Nijmegen
The Netherlands
Phone number: +31-24-3613608
Fax number: +31-24-3613425
Email address: a.evers@mps.umcn.nl
dr. A.W.M. Evers 1,2,3, drs. M. Ferwerda 1, drs. S. van Beugen 1, dr. E. de Jong 3, dr. W. Kievit 2 , prof. M. van de Laar 4,5 , dr. E. Taal 4, prof. dr. P.C.M. van de Kerkhof 3, prof. dr. P.L.C.M. van Riel 2
1 Department of Medical Psychology, Radboud University Nijmegen Medical Centre, The Netherlands
2 Department of Rheumatology, Radboud University Nijmegen Medical Centre, The Netherlands
3 Department of Dermatology, Radboud University Nijmegen Medical Centre, The Netherlands
4 Department of Psychology, University of Twente, The Netherlands
5 Department of Rheumatology, Medisch Spectrum Twente, The Netherlands
Topic: E-coaching (Special topic, Medicine 2.0 “10)
Objectives: Psychological adjustment problems of high-risk patients with chronic somatic conditions, such as rheumatoid arthritis (RA), psoriasis (PS) and arthritis psoriatica (PSA), can be successfully treated by tailored cognitive-behavior therapy (CBT). Offering this tailored CBT by E-coaching for patients at risk might be a promising way to offer these treatments more cost-effectively. The aim of the study is to investigate the feasibility and effectiveness of tailored CBT through E-coaching for risk groups of patients with RA, PS and PSA.
Target groups: Patients with chronic somatic conditions.
Methodology: Patients’ satisfaction and the feasibility of tailored CBT by E-coaching for patients at risk were studied in a pilot study. Patients’ perspective with regard to possible advantages and disadvantages to participate in the treatment were additionally determined. In the randomized, controlled trial , patients with RA, PS and PSA were screened for cognitive-behavioral risk profiles, and subsequently were randomized to tailored E-coaching CBT or a control group.
Results: Results of the pilot study indicate that applying tailored E-coaching CBT to risk groups of RA, PSA and PSA patients is feasible and more advantages than disadvantages are perceived by patients for E-health treatments. Preliminary results on the effectiveness of the treatments in the treatment group suggest beneficial effects for physical and psychological functioning and low dropout rates during therapy.
Conclusion: E-coaching by tailored CBT for patients with chronic somatic conditions, such as RA, PS or PSA, seems to be feasible and a promising new cost-effective way to offer cognitive-behavioral treatment to patients who are at risk for psychological adjustment problems. Preliminary results of the randomized, controlled trials suggest high adherence and high patient satisfaction.
Correspondance:
Andrea W.M. Evers, PhD
Department of Medical Psychology 840
Radboud University Nijmegen Medical Centre
P.O. Box 9101
6500 HB Nijmegen
The Netherlands
Phone number: +31-24-3613608
Fax number: +31-24-3613425
Email address: a.evers@mps.umcn.nl
Medicine 2.0® is happy to support and promote other conferences and workshops in this area. Contact us to produce, disseminate and promote your conference or workshop under this label and in this event series. In addition, we are always looking for hosts of future World Congresses. Medicine 2.0® is a registered trademark of JMIR Publications Inc., the leading academic ehealth publisher.
This work is licensed under a Creative Commons Attribution 3.0 License.